Crohn's disease complicated by primary gastrointestinal Hodgkin's lymphoma presenting with small bowel perforation

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 3, 2009, Pages 359-361

  Castrellon, Aurelio ^a   Feldman, Paul Andrew ^b   Suarez, Miguel ^b   Spector, Seth ^b   Chua, Lucy ^b   Byrnes, John ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anti TNF therapy; Crohn's disease; Hodgkin's lymphoma; Immunomodulators

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; INFLIXIMAB; LEFLUNOMIDE; MERCAPTOPURINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VINBLASTINE;

AGED; ARTHRITIS; ARTICLE; BIOLOGICAL THERAPY; CASE REPORT; CROHN DISEASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; HODGKIN DISEASE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; INTESTINE PERFORATION; MALE; SMALL INTESTINE; EPSTEIN BARR VIRUS; GASTROINTESTINAL TUMOR; ILEUM DISEASE; ISOLATION AND PURIFICATION;

AGED; CROHN DISEASE; GASTROINTESTINAL NEOPLASMS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; ILEAL DISEASES; INTESTINAL PERFORATION; MALE;

EID: 73949090154     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis pp. the risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007; 50: 839-855.
2. Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001; 121: 1080-1087.
3. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54: 1121-1125.
4. Bongartz t, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-tNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275-2285.
5. Codling BW, Keighley MR, Slaney G. Hodgkin's disease complicating Crohn's colitis. Surgery 1977; 82: 625-628.
6. Kumar S, Fend F, Quintanilla-Martinez L, et al. Epstein-Barr viruspositive primary gastrointestinal Hodgkin's disease: association with inflammatory bowel disease and immunosuppression. Am J Surg pathol 2000; 24: 66-73.
7. Bai M, Katsanos KH, Economou M, et al. Rectal Epstein-Barr viruspositive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature. Scand J Gastroenterol 2006; 41: 866-869.
8. Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers prev 2006; 15: 2069-2077
9. Gottschalk S, Rooney CM, Heslop HE. post-transplant lymphoproliferative disorders. Annu Rev Med 2005; 56: 29-44.
10. Uccini S, Monardo F, Stoppacciaro A, et al. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIVpositive patients. Int J Cancer 1990; 46: 581-585.